• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

基于临床和超声参数的列线图模型用于预测股浅动脉支架置入术后再狭窄的研究

Development of a Clinical and Ultrasonic Parameter-Based Nomogram Model to Predict Restenosis after Superficial Femoral Artery Stenting.

作者信息

Wang Yiwei, Gao Mingjie, Zhao Xinyu, Han Peng, Zhang Libo, Dardik Alan

机构信息

Department of Ultrasound in Medicine, Beijing Luhe Hospital, Capital Medical University, Beijing, China.

Department of Ultrasound in Medicine, Beijing Luhe Hospital, Capital Medical University, Beijing, China.

出版信息

Ann Vasc Surg. 2025 Apr;113:175-185. doi: 10.1016/j.avsg.2024.12.068. Epub 2025 Jan 23.

DOI:10.1016/j.avsg.2024.12.068
PMID:39855385
Abstract

BACKGROUND

Prediction of in-stent restenosis (ISR) is clinically important for patients with peripheral artery disease (PAD) in superficial femoral artery (SFA) who have been treated with stenting. The aim of this study was to construct and validate a predictive model for ISR after SFA stenting based on a series of clinical and ultrasonic parameters.

METHODS

This retrospective study included 381 patients who were treated with self-expanding bare nitinol stents in their SFA at our hospital between January 1, 2018, and January 1, 2022. These patients were randomly allocated to a training cohort (266 patients) or a validation cohort (115). Clinical and ultrasonic parameters related to ISR (>50%) in the SFA at 12 months were derived by univariable and multivariable logistic regression analyses to create a nomogram model predictive of risk of ISR. Receiver operating characteristic (ROC) curve analyses were used to assess the recognition ability of the model. A calibration curve was used to evaluate the model's calibration ability, and decision curve analysis was used to validate the nomogram's clinical utility.

RESULTS

Logistic regression analyses showed that sex, echogenicity of the target plaque, preoperative arterial runoff score, preoperative popliteal artery flow rate, lesion length, and residual diameter were risk factors for ISR; these parameters were used to construct the nomogram model. Internal and external validation showed that the areas under the ROC curves were 0.82 (95% CI: 0.77-0.87) and 0.70 (95% CI: 0.60-0.79), respectively, suggesting good recognition ability of the model. Additionally, calibration curves for the predictive model indicated good calibration, and the decision curve analysis demonstrated clinical utility of the model.

CONCLUSION

This novel nomogram that predicts ISR after SFA stenting demonstrated excellent discriminatory power, calibration capacity, and clinical usefulness.

摘要

背景

对于接受支架置入治疗的股浅动脉(SFA)外周动脉疾病(PAD)患者,预测支架内再狭窄(ISR)具有重要的临床意义。本研究旨在基于一系列临床和超声参数构建并验证SFA支架置入术后ISR的预测模型。

方法

本回顾性研究纳入了2018年1月1日至2022年1月1日期间在我院接受SFA自膨式裸镍钛合金支架治疗的381例患者。这些患者被随机分为训练队列(266例患者)或验证队列(115例)。通过单变量和多变量逻辑回归分析得出与12个月时SFA中ISR(>50%)相关的临床和超声参数,以创建预测ISR风险的列线图模型。采用受试者操作特征(ROC)曲线分析评估模型的识别能力。使用校准曲线评估模型的校准能力,并使用决策曲线分析验证列线图的临床实用性。

结果

逻辑回归分析显示,性别、目标斑块的回声性、术前动脉血流评分、术前腘动脉血流速度、病变长度和残余直径是ISR的危险因素;这些参数用于构建列线图模型。内部和外部验证显示,ROC曲线下面积分别为0.82(95%CI:0.77-0.87)和0.70(95%CI:0.60-0.79),表明模型具有良好的识别能力。此外,预测模型的校准曲线显示校准良好,决策曲线分析证明了模型的临床实用性。

结论

这种预测SFA支架置入术后ISR的新型列线图具有出色的区分能力、校准能力和临床实用性。

相似文献

1
Development of a Clinical and Ultrasonic Parameter-Based Nomogram Model to Predict Restenosis after Superficial Femoral Artery Stenting.基于临床和超声参数的列线图模型用于预测股浅动脉支架置入术后再狭窄的研究
Ann Vasc Surg. 2025 Apr;113:175-185. doi: 10.1016/j.avsg.2024.12.068. Epub 2025 Jan 23.
2
Intravascular Ultrasound-Derived Stent Dimensions as Predictors of Angiographic Restenosis Following Nitinol Stent Implantation in the Superficial Femoral Artery.血管内超声衍生的支架尺寸作为股浅动脉镍钛诺支架植入术后血管造影再狭窄的预测指标
J Endovasc Ther. 2016 Jun;23(3):424-32. doi: 10.1177/1526602816641669. Epub 2016 Apr 4.
3
Predicting and Analyzing Restenosis Risk after Endovascular Treatment in Lower Extremity Arterial Disease: Development and Assessment of a Predictive Nomogram.预测与分析下肢动脉疾病血管内治疗后的再狭窄风险:预测列线图的开发与评估
J Endovasc Ther. 2024 Dec;31(6):1140-1149. doi: 10.1177/15266028231158294. Epub 2023 Mar 8.
4
Duplex criteria for in-stent restenosis in the superficial femoral artery.股浅动脉支架内再狭窄的双标准。
Catheter Cardiovasc Interv. 2013 Mar;81(4):E199-205. doi: 10.1002/ccd.24509. Epub 2012 Nov 14.
5
Comparison of the risk scoring systems in long term restenosis due to percutaneous interventions to the superficial femoral artery.经皮介入治疗股浅动脉后长期再狭窄风险评分系统的比较。
Vasa. 2025 May;54(3):184-191. doi: 10.1024/0301-1526/a001178. Epub 2025 Jan 30.
6
Registry Assessment of Peripheral Interventional Devices objective performance goals for superficial femoral and popliteal artery peripheral vascular interventions.外周血管介入器械注册评估——股浅动脉和腘动脉外周血管介入的客观性能目标。
J Vasc Surg. 2021 May;73(5):1702-1714.e11. doi: 10.1016/j.jvs.2020.09.030. Epub 2020 Oct 17.
7
Development and validation of a risk prediction nomogram for in-stent restenosis in patients undergoing percutaneous coronary intervention.经皮冠状动脉介入治疗患者支架内再狭窄风险预测列线图的建立与验证。
BMC Cardiovasc Disord. 2021 Sep 14;21(1):435. doi: 10.1186/s12872-021-02255-4.
8
Impact of IVUS-Derived Vessel Size on Midterm Outcomes After Stent Implantation in Femoropopliteal Lesions.血管内超声指导下的血管大小对股腘动脉病变支架植入术后中期结果的影响。
J Endovasc Ther. 2020 Feb;27(1):77-85. doi: 10.1177/1526602819896293.
9
Impact of Cilostazol Administration on Femoropopliteal In-Stent Restenosis.西洛他唑对股腘动脉支架内再狭窄的影响。
J Endovasc Ther. 2017 Oct;24(5):640-646. doi: 10.1177/1526602817719284. Epub 2017 Jul 5.
10
Combination therapy of heparin-bonded covered stent and bare-nitinol stent assessed by intravascular ultrasound.血管内超声评估肝素涂层覆膜支架与裸镍钛诺支架的联合治疗
Heart Vessels. 2020 Nov;35(11):1502-1509. doi: 10.1007/s00380-020-01631-y. Epub 2020 May 27.